Zhejiang-based hospital technology developer Helian Health has raised US$75 million (HK$585 million) from a Series B funding round last Friday.
Hong Kong unicorn SenseTime led the latest round, and was joined by other participants including Hangzhou Lianchuan Investment, the Hong Kong Economic Journal reports.
The latest round values Helian Health at around US$1 billion, paving the way for it to become a so-called unicorn.
According to the Chinese startup’s co-founder, Ye Anping, the new funds will be used to further enhance the technology capabilities in hospital smart management system, so as to lure more doctors into Helian Health’s medical service and healthcare platform.
The company aims to meet the technical requirement for providing all-rounded smart health care for 100 million users by 2020.
Xu Bing, co-founder of SenseTime, said Helian’s attraction lies in its leading position in hospital technology and the special advantage that its application has for IoT in hospitals, among other things.
Xu believes the AI technology of SenseTime can contribute to Helian’s development in the smart medical service sector.
Established in 2014 from the wireless department of Lianlian International, Helian Health covers 245 cities and around 1,700 hospitals in China, with the number doctors on its platform said to be excess of 1.4 million.
In October last year, the company raised 60 million yuan in ar Series A round involving Marathon Venture Partners and 6 Dimensions Capital.
SenseTime, meanwhile, attracted US$620 million in Series C+ from Fidelity International, Hopu Capital, Silver Lake, and Tiger Global last month.
The AI developer focuses on computer vision, deep learning, and medical imaging.
Together with the Hong Kong Science and Technology Parks Corporation, SenseTime set up an accelerator program “HKAI Lab” last month to help startups.